918967-55-2

Basic information

• Product Name: Benzoic acid, 2-fluoro-4-[(hydroxyamino)iminomethyl]-, methyl ester
• CAS NO: 918967-55-2
• Molecular Formula: C9H9FN2O3
• Molecular Weight: 212.18
• Mol File: 918967-55-2.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-fluoro-4-[(hydroxyamino)iminomethyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-fluoro-4-[(hydroxyamino)iminomethyl]-, methyl ester(918967-55-2)
• EPA Substance Registry System: Benzoic acid, 2-fluoro-4-[(hydroxyamino)iminomethyl]-, methyl ester(918967-55-2)

Safety Data

• Hazardous Substances Data: 918967-55-2(Hazardous Substances Data)

Upstream product

• 164149-28-4 4-cyano-2-fluorobenzoic acid 
• 175596-01-7 methyl 4-cyano-2-fluorobenzoate 

Downstream Products

• 1141471-65-9 2-fluoro-4-[5-(2’-methoxy-2-methylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl]benzoic acid 
• 1141471-81-9 2-fluoro-4-{5-[2’-methyl-2-(trifluoromethyl)biphenyl-4-yl]1,2,4-oxadiazol-3-yl}benzoic acid 
• 1141471-71-7 2-fluoro-4-[5-(2-methoxy-2’-methylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl]benzoic acid 
• 1141471-62-6 4-[5-(2,2’-dimethylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl]-2-fluorobenzoic acid 
• 1141471-63-7 2-fluoro-4-[5-(2’-methylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl]benzoic acid 
• 1141471-64-8 2-fluoro-4-[5-(2-methylbiphenyl-4-yl)-1,2,4-oxadiazol-3-yl]benzoic acid 
• 1141472-98-1 methyl 4-[(2-fluoro-4-{5-[2-(methoxymethyl)-2'-methylbiphenyl-4-yl]-1,2,4-oxadiazol-3-yl}benzoyl)amino]butanoate 
• 1141472-89-0 methyl N-(2-fluoro-4-{5-[2-(methoxymethyl)-2'-methylbiphenyl-4-yl]-1,2,4-oxadiazol-3-yl}benzoyl)-beta-alaninate 

Relevant articles and documents

BICYCLOHETEROARYL-HETEROARYL-BENZOIC ACID COMPOUNDS AS RETINOIC ACID RECEPTOR BETA (RARβ) AGONISTS

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain bicycloheteroaryl-heteroaryl-benzoic acid compounds of the following formula (for convenience, collectively referred to herein as "BHBA compou

AMIDE DERIVATIVE

Provided are a compound having an excellent hypoglycemic action, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.

TRIAZOLE OXADIAZOLES DERIVATIVES

The invention relates to compounds of formula (I), wherein R1, R2, Ra, Rb, X have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.